Revenue
2018
2019
2020
2021
2022
2023
2024
2025
OptimizeRx Corp (OPRX)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109.4M | $92.1M | $71.5M | $1.0M | $4.5M | $43.3M | $24.6M | $21.2M | $12.1M | $7.8M | $7.2M | $6.5M | $4.7M | $2.0M | $1.1M | $71,065 |
| Gross profit | $73.6M | $59.4M | $42.9M | $39.0M | $35.6M | $24.1M | $15.4M | $12.2M | $6.0M | $4.3M | $3.6M | $3.3M | $2.8M | $1.9M | — | — |
| Research & development | $0 | $0 | — | — | — | $0 | $1.6M | $0 | — | — | — | — | — | — | — | — |
| Operating expenses | $61.9M | $73.1M | $69.3M | $51.3M | $35.3M | $26.2M | $19.1M | $12.0M | $8.1M | $5.9M | $4.2M | $4.3M | $3.1M | $2.3M | $2.6M | $1.9M |
| Operating income | $11.7M | −$13.7M | −$26.4M | −$12.3M | $361,100 | −$2.1M | −$3.7M | $180,132 | −$2.1M | −$1.6M | −$597,407 | −$1.0M | −$267,536 | −$454,922 | −$1.5M | −$1.8M |
| EBITDAderived | $16.0M | −$9.4M | −$24.0M | −$10.3M | $2.3M | −$59,431 | −$2.4M | $496,634 | −$1.8M | −$1.3M | −$263,457 | −$761,988 | −$73,745 | −$267,818 | −$1.3M | −$1.8M |
| Net income | $5.1M | −$20.1M | −$17.6M | −$11.4M | $378,079 | −$2.2M | −$3.1M | $226,344 | −$2.1M | −$1.5M | −$595,140 | −$1.0M | −$267,290 | −$454,553 | −$2.1M | −$2.0M |
| Basic EPSper diluted share | $0.28 | -$1.10 | -$1.03 | -$0.64 | $0.02 | -$0.15 | -$0.23 | $0.02 | -$0.21 | -$0.05 | -$0.02 | -$0.04 | -$0.02 | — | — | — |
| Diluted EPSper diluted share | $0.27 | -$1.10 | -$1.03 | -$0.64 | $0.02 | -$0.15 | -$0.23 | $0.02 | -$0.21 | -$0.05 | — | -$0.04 | -$0.02 | — | — | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 19, 2025Form 4 | Stelmakh EdwardChief Finance & Strat Officer | SellCommon Stock | 1.4K | $13.51 | $18.8K | 126.8K |
| Oct 3, 2025Form 4 | Silvestro Stephen LChief Executive Officer | SellCommon Stock | 1.6K | $18.75 | $30.4K | 188.9K |
| Aug 28, 2025Form 4 | Spangler Patrick DDirector | SellCommon Stock | 11.1K | $17.49 | $194.5K | 44.2K |
| Mar 14, 2025Form 4 | Lang James PaulDirector | BuyCommon Stock | 321.4K | $7.60 | $2.44M | 389.5K |
| Dec 12, 2024Form 4 | FEBBO WILLIAM JCEO | BuyCommon Stock | 20.0K | $5.01 | $100.2K | 601.3K |